EU approves AstraZeneca’s drug for adjunct use in Type-1 diabetes

Type-1 diabetes is a chronic condition in which the pancreas produces little or no insulin hormone.

Original source: https://health.economictimes.indiatimes.com/news/pharma/eu-approves-astrazenecas-drug-for-adjunct-use-in-type-1-diabetes/68559668?utm_source=RSS&utm_medium=ETRSS